BBCMF (Lir Life Sciences) Inventory-to-Revenue: (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BBCMF Lir Life Sciences Corp BBCMF
14 GF Score
Price $0.20
! 2 Warning Signs
View Full Analysis

What is Lir Life Sciences Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Lir Life Sciences's Average Total Inventories for the quarter that ended in Apr. 2026 was $0.00 Mil. Lir Life Sciences's Revenue for the three months ended in Apr. 2026 was $0.00 Mil.

Lir Life Sciences's Inventory-to-Revenue for the quarter that ended in Apr. 2026 stayed the same from Jan. 2026 () to Jan. 2026 ()

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Lir Life Sciences's Days Inventory for the three months ended in Apr. 2026 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.


Lir Life Sciences  (OTCPK:BBCMF) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Lir Life Sciences's Days Inventory for the three months ended in Apr. 2026 is calculated as:

Days Inventory=Average Total Inventories (Q: Apr. 2026 )/Cost of Goods Sold (Q: Apr. 2026 )*Days in Period
=0/0.0009338427366426*365 / 4
=0.00

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Lir Life Sciences's Inventory Turnover for the quarter that ended in Apr. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Apr. 2026 ) / Average Total Inventories (Q: Apr. 2026 )
=0.0009338427366426 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lir Life Sciences Inventory-to-Revenue Related Terms


Lir Life Sciences Inventory-to-Revenue Historical Data

* Premium members only.

The historical data trend for Lir Life Sciences's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lir Life Sciences Inventory-to-Revenue Chart

Lir Life Sciences Annual Data
Trend Jan21 Jan22 Jan23 Apr24 Apr25 Apr26
Inventory-to-Revenue
Get a 7-Day Free Trial - - - - -

Lir Life Sciences Quarterly Data
Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Jul23 Oct23 Jan24 Apr24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BBCMF vs VRTX, REGN, MRNA: Inventory-to-Revenue Comparison

For the Biotechnology subindustry, Lir Life Sciences's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lir Life Sciences Inventory-to-Revenue vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lir Life Sciences's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Lir Life Sciences's Inventory-to-Revenue falls into.


BBCMF
14GF Score
Lir Life Sciences Corp BBCMF
Inventory-to-Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lir Life Sciences Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Lir Life Sciences's Inventory-to-Revenue for the fiscal year that ended in Apr. 2026 is calculated as

Inventory-to-Revenue (A: Apr. 2026 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Apr. 2025 ) + Total Inventories (A: Apr. 2026 )) / count ) / Revenue (A: Apr. 2026 )
=( (0 + 0) / 1 ) / 0
=0 / 0
=N/A

Lir Life Sciences's Inventory-to-Revenue for the quarter that ended in Apr. 2026 is calculated as

Inventory-to-Revenue (Q: Apr. 2026 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Jan. 2026 ) + Total Inventories (Q: Apr. 2026 )) / count ) / Revenue (Q: Apr. 2026 )
=( (0 + 0) / 1 ) / 0
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lir Life Sciences Business Description

Other Exchanges N790:GermanySKNY:Canada
Address 505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
14GF Score

Get the complete analysis for BBCMF

Inventory-to-Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.20
Price